Shukra Pharmaceuticals Ltd
company logo

Shukra Pharmaceuticals Ltd

Pharmaceuticals
Small Cap

-

- (0%)

Shukra Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Shukra Pharmaceuticals Ltd Fundamentals

368.91Cr

19.92

6.40

0.20

4.23

0.30%

13.16

i buttonClick here to know more about Fundamentals

Shukra Pharmaceuticals Ltd Financials

Shukra Pharmaceuticals Ltd Financialsright-arrow

Shukra Pharmaceuticals Ltd Shareholding Pattern

Shukra Pharmaceuticals Ltd Delivery and Volume

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016. The Company is presently engaged in the busine

Dakshesh Shah

1993

-

NameDesignation
Dakshesh ShahChairman & Managing Director
Payal MehtaExecutive Director
Bhoomiben PatelIndependent Director
Sarjeevan SinghIndependent Director
Sonal Deepalbhai GandhiIndependent Director
Sanskruti PatelExecutive Director
Dhruvin ShahExecutive Director
Pinki Nirmal SagarIndependent Director
News and Events...

Similar Stocks

What's Trending

Shukra Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Shukra Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Shukra Pharmaceuticals Ltd's share price is ₹84.25 as of 2024-07-21.
Shukra Pharmaceuticals Ltd's P/E ratio is 19.92 times as of 2024-07-21.
Shukra Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 6.4, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Shukra Pharmaceuticals Ltd's market capitalization is ₹368.91 Cr as on 2024-07-21.
The current financial records of Shukra Pharmaceuticals Ltd show a 21.18% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Shukra Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹53.07, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Shukra Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Shukra Pharmaceuticals Ltd's 52-week high and low as of 2024-07-21 are ₹84.25 and ₹84.25, respectively.